{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:37:22Z","timestamp":1777894642431,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014261","name":"NIHCM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014499","name":"Stanford Diabetes Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019604","name":"Stanford University Stanford Research Computing Center","doi-asserted-by":"publisher","award":["P30DK116074"],"award-info":[{"award-number":["P30DK116074"]}],"id":[{"id":"10.13039\/100019604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ajt.2025.12.015","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:06:43Z","timestamp":1766124403000},"page":"729-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic venetoclax and anti-CD3 therapy for control of alloreactive response in hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4642-3856","authenticated-orcid":false,"given":"Bettina P.","family":"Iliopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-8516","authenticated-orcid":false,"given":"Shiva","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9775-1315","authenticated-orcid":false,"given":"Blake","family":"Mosher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7572-0136","authenticated-orcid":false,"given":"Levon","family":"Witherspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-0113","authenticated-orcid":false,"given":"Cameron S.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8267-2190","authenticated-orcid":false,"given":"Pin-I","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2638-2436","authenticated-orcid":false,"given":"Nadine","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-3267","authenticated-orcid":false,"given":"Alejandro","family":"Villar-Prados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9721-4379","authenticated-orcid":false,"given":"Kent","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-853X","authenticated-orcid":false,"given":"Everett H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ajt.2025.12.015_bib1","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1158\/0008-5472.CAN-05-1175","article-title":"Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res"},{"issue":"1 Pt 1","key":"10.1016\/j.ajt.2025.12.015_bib2","first-page":"245","article-title":"Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia","volume":"13","author":"Warren","year":"1981","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.015_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2141.2005.05667.x","article-title":"Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up","volume":"130","author":"Kahl","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajt.2025.12.015_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21037\/sci.2017.05.02","article-title":"Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly","volume":"4","author":"de Koning","year":"2017","journal-title":"Stem Cell Investig"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.015_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbmt.2005.05.001","article-title":"Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation","volume":"11","author":"Kakhniashvili","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.015_bib6","doi-asserted-by":"crossref","first-page":"851.e1","DOI":"10.1016\/j.jtct.2021.06.004","article-title":"Full dose cyclophosphamide with the addition of fludarabine for matched sibling transplants in severe aplastic anemia","volume":"27","author":"El","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"25","key":"10.1016\/j.ajt.2025.12.015_bib7","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.015_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41409-023-02042-z","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm","volume":"58","author":"Rieger","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.015_bib9","doi-asserted-by":"crossref","first-page":"851 e1","DOI":"10.1016\/j.jtct.2021.06.004","article-title":"Full dose cyclophosphamide with the addition of fludarabine for matched sibling transplants in severe aplastic anemia","volume":"27","author":"El Fakih","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"24","key":"10.1016\/j.ajt.2025.12.015_bib10","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1182\/bloodadvances.2021004846","article-title":"Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era","volume":"5","author":"Yeh","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.015_bib11","doi-asserted-by":"crossref","first-page":"455.e1","DOI":"10.1016\/j.jtct.2023.03.029","article-title":"Clinical features of acute kidney injury in the early post-transplantation period following reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Vergara-Cadavid","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.015_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111615","article-title":"Curative islet and hematopoietic cell transplantation in diabetic mice without toxic bone marrow conditioning","volume":"41","author":"Chang","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajt.2025.12.015_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805177","article-title":"Establishment of chimerism and organ transplant tolerance in laboratory animals: safety and efficacy of adaptation to humans","volume":"13","author":"Lowsky","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.12.015_bib14","article-title":"Tregs and mixed chimerism as approaches for tolerance induction in islet transplantation","volume":"11","author":"Pathak","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.015_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/imt-2016-0049","article-title":"Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside","volume":"8","author":"Kuhn","year":"2016","journal-title":"Immunotherapy"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.015_bib16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/dc23-0675","article-title":"Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves beta-cell function","volume":"46","author":"Herold","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.015_bib17","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.1100713","article-title":"Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells","volume":"187","author":"Penaranda","year":"2011","journal-title":"J Immunol."},{"issue":"23","key":"10.1016\/j.ajt.2025.12.015_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ajhp\/zxac244","article-title":"Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: a literature review","volume":"79","author":"LeFevre","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.015_bib19","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41418-018-0228-y","article-title":"Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes","volume":"26","author":"Jiao","year":"2019","journal-title":"Cell Death Differ"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.015_bib20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/cmi.12340","article-title":"Lipid interactions during virus entry and infection","volume":"16","author":"Mazzon","year":"2014","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.015_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI32562","article-title":"Immunostimulatory Tim-1\u2013specific antibody deprograms Tregs and prevents transplant tolerance in mice","volume":"118","author":"Degauque","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajt.2025.12.015_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.exer.2014.02.019","article-title":"Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice","volume":"122","author":"Tan","year":"2014","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.015_bib23","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1016\/j.ajt.2025.12.015_bib24","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1182\/bloodadvances.2019000286","article-title":"Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation","volume":"3","author":"Iliopoulou","year":"2019","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.ajt.2025.12.015_bib25","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1182\/blood-2014-05-576017","article-title":"CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells","volume":"124","author":"Schneidawind","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.015_bib26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood-2002-06-1751","article-title":"Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging","volume":"101","author":"Edinger","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.015_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ajt.2025.12.015_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.07.007","article-title":"Sensing and clearance of apoptotic cells","volume":"68","author":"Nagata","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.015_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/dbio.2002.0779","article-title":"Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators","volume":"250","author":"Balemans","year":"2002","journal-title":"Dev Biol"},{"issue":"16","key":"10.1016\/j.ajt.2025.12.015_bib30","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/bloodadvances.2019000297","article-title":"Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort","volume":"3","author":"Spinner","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.015_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/ajt.13091","article-title":"Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation","volume":"15","author":"Scandling","year":"2015","journal-title":"Am J Transplant"},{"issue":"23","key":"10.1016\/j.ajt.2025.12.015_bib32","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1182\/bloodadvances.2019000134","article-title":"PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade","volume":"3","author":"Ikegawa","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.015_bib33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.015_bib34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3727\/096368910X514639","article-title":"Role of CCL2\/MCP-1 in islet transplantation","volume":"19","author":"Melzi","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ajt.2025.12.015_bib35","article-title":"Role of MCP-1 as an inflammatory biomarker in nephropathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.015_bib36","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.168.4.1636","article-title":"CD8+, \u03b1\u03b2-TCR+, and \u03b3\u03b4-TCR+ cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow","volume":"168","author":"Xu","year":"2002","journal-title":"J Immunol"},{"issue":"690","key":"10.1016\/j.ajt.2025.12.015_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add5318","article-title":"Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primates","volume":"15","author":"Sasaki","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajt.2025.12.015_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749094","article-title":"Venetoclax or ruxolitinib in pre-transplant conditioning lowers the engraftment barrier by different mechanisms in allogeneic stem cell transplant recipients","volume":"12","author":"Davis","year":"2021","journal-title":"Front Immunol"},{"issue":"46","key":"10.1016\/j.ajt.2025.12.015_bib39","doi-asserted-by":"crossref","first-page":"69635","DOI":"10.1007\/s11356-022-20441-5","article-title":"Ameliorative effect of flavocoxid on cyclophosphamide-induced cardio and neurotoxicity via targeting the GM-CSF\/NF-\u03baB signaling pathway","volume":"29","author":"Elsayed","year":"2022","journal-title":"Environ Sci Pollut Res Int"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.015_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.6004\/jadpro.2023.14.6.5","article-title":"Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner","volume":"14","author":"Kachur","year":"2023","journal-title":"J Adv Pract Oncol"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.015_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41409-020-01092-x","article-title":"Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching","volume":"56","author":"Irene","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"10.1016\/j.ajt.2025.12.015_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121717","article-title":"Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models","volume":"3","author":"Wolf","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.015_bib43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbmt.2015.12.016","article-title":"Cytokine profile of engraftment syndrome in pediatric hematopoietic stem cell transplant recipients","volume":"22","author":"Khandelwal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.015_bib44","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V96.9.2973","article-title":"T-lymphocyte production of macrophage inflammatory protein-1\u03b1 is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease","volume":"96","author":"Serody","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajt.2025.12.015_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fimmu.2016.00148","article-title":"Interleukin-22 in graft-versus-host disease after allogeneic stem cell transplantation","volume":"7","author":"Lamarth\u00e9e","year":"2016","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.015_bib46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","article-title":"Targeted elimination of senescent beta cells prevents type 1 diabetes","volume":"29","author":"Thompson","year":"2019","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.ajt.2025.12.015_bib47","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.4049\/jimmunol.177.10.6603","article-title":"Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells","volume":"177","author":"Brode","year":"2006","journal-title":"J Immunol."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525031740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525031740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:27:51Z","timestamp":1777620471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525031740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1600613525031740"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.12.015","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic venetoclax and anti-CD3 therapy for control of alloreactive response in hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}